• /
  • Brussels, Bruxelles-Capitale, Belgium
  • Permanent, Full time
  • Candriam
  • 2018-09-11

Senior Biotechnology Analyst

As part of the Thematic Global Equity team of 8 professionals, you will assist in the management of the Candriam Biotechnology strategy, a successful and fast growing 1,5 billion USD specialist strategy investing in a global selection of listed biotechnology companies.

RESPONSIBILITIES

  • You analyse the public medical data of investigational drugs, both in the pre-clinical setting as well as in human trials. To this end, you also interact with biotechnology company representatives from the scientific staff up to the CEO level. 
  • You put the clinical data in the context of the targeted disease, implying research on the disease characteristics and characteristics of existing treatments.
  • You establish a commercial sales target for the drug(s) once approved, by analysing the prevalence of the disease, the price of existing treatments and the competitive positioning of the investigational drug. 
  • You built a relationship of trust with external analysts and represent Candriam at broker  and/or medical conferences.
  • You establish a fair value for the companies under your assessment using our well vetted valuation methodology and, over time,  help brainstorming on how to further improve our investment process and valuation work.

PROFILE

  • You hold a degree in biotechnology/life sciences. An additional financial degree a strong plus.
  • Prior experience in a financial and/or research environment (wet or dry lab) a strong plus.
  • You are passionate about equity research and investing.
  • You are a team player; determination and ambition are a given.
  • You have an investigational mind set and leave no stone unturned when analyzing a situation.
  • You are fluent in English, both spoken and written.
Brussels, Bruxelles-Capitale, Belgium Brussels Bruxelles-Capitale BE